Human TNFSF13B (Tumor Necrosis Factor Ligand Superfamily Member 13B) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05088P
SDS-PAGE analysis of Human TNFSF13B (Tumor Necrosis Factor Ligand Superfamily Member 13B) - Recombinant Protein, CAT# BLT-05088P, showing >95% purity under 15% SDS-PAGE (Reduced)
Human TNFSF13B (Tumor Necrosis Factor Ligand Superfamily Member 13B) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05088P
Regular price
$59500
$595.00
Sale price$54500
$545.00Save $50
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $1,375 |
| 1 mg | $2,245 |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Eukaryotic B-Cell Activating Factor (BAFF/TNFSF13B) Protein |
| Product Overview | This recombinant human Eukaryotic B-Cell Activating Factor (BAFF/TNFSF13B) protein includes amino acids 134-285aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id | Q9Y275 |
| Recommended Name | Tumor necrosis factor ligand superfamily member 13B |
| Gene Name | TNFSF13B |
| Synonyms | BAFF;BLYS;CD257;DTL;TALL-1;TALL1;THANK;TNFSF20;ZTNF4 |
| Species | Human |
| Predicted Molecular Mass | 44 kDa |
| Expression System | E.coli |
| Expression Range | 134-285aa |
| Tag | C-Fc |
| Purity | >95% |
| Formulation | Lyophilized |
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Cancer |
| Target Function | Cytokine that binds to TNFRSF13B/TACI and TNFRSF17/BCMA. TNFSF13/APRIL binds to the same 2 receptors. Together, they form a 2 ligands -2 receptors pathway involved in the stimulation of B- and T-cell function and the regulation of humoral immunity. A third B-cell specific BAFF-receptor (BAFFR/BR3) promotes the survival of mature B-cells and the B-cell response.; Isoform 2 seems to inhibit isoform 1 secretion and bioactivity.; Acts as a transcription factor for its own parent gene, in association with NF-kappa-B p50 subunit, at least in autoimmune and proliferative B-cell diseases. The presence of Delta4BAFF is essential for soluble BAFF release by IFNG/IFN-gamma-stimulated monocytes and for B-cell survival. It can directly or indirectly regulate the differential expression of a large number of genes involved in the innate immune response and the regulation of apoptosis. |
| Subcellular Location | Cell membrane; Single-pass type II membrane protein.; [Tumor necrosis factor ligand superfamily member 13b, soluble form]: Secreted. |
| Protein Family | Tumor necrosis factor family |
| Tissue Specificity | Abundantly expressed in peripheral blood Leukocytes and is specifically expressed in monocytes and macrophages. Also found in the spleen, lymph node, bone marrow, T-cells and dendritic cells. A lower expression seen in placenta, heart, lung, fetal liver, |
